Accel, the prominent global venture capital firm, is reportedly in advanced discussions to lead a funding round of $30 million to $40 million in Truemeds, an innovative Indian online pharmacy focused on making healthcare more accessible through affordable generic medications. According to multiple sources familiar with the negotiations, the proposed valuation for the six-year-old startup stands at…
